(EL-2) or 4.1.6.2. Four cycles of paclitaxel, ifosfamide and cisplatin (TIP) regimen [12] (EL-2). 4.1.7. Management of patients failing second-line chemotherapy: Patients will be treated with combination paclitaxel and Gemcitabine for those who did not receive paclitaxel before. [13] 4. [20, 21] if the n o d a l m e t a s t a s i s i s i n t h e p r i m a r y l a n d i n g z o n e i n s e l e c t e d p a t i e n t s . [25] w i t h E P, VIP or TIP (see below) (EL-2 [12] 4.2.5. Management of patients failing second line chemotherapy: Patients will be treated with paclitaxel and Gemcitabine if did not receive paclitaxel before. [13] 4.2.6. Management of patients failing all lines of chemotherapy: In the case of markers progression after salvage treatment and exhaustion of all possible chemotherapeutic options, resection of residual tumors (desperation surgery) should be considered if complete resection of all tumors seems technically feasible. [26] 
